Cerevel Therapeutics (CERE)
(Delayed Data from NSDQ)
$40.31 USD
-0.74 (-1.80%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $40.33 +0.02 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.58 | 0.00% |
Earnings Summary
For their last quarter, Cerevel Therapeutics (CERE) reported earnings of -$0.73 per share, missing the Zacks Consensus Estimate of -$0.61 per share. This reflects a negative earnings surprise of 19.67%. Look out for CERE's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.58 per share, reflecting a year-over-year increase of 7.94%.
Earnings History
Price & Consensus
Zacks News for CERE
After Plunging -5.14% in 4 Weeks, Here's Why the Trend Might Reverse for Cerevel Therapeutics (CERE)
CERE: What are Zacks experts saying now?
Zacks Private Portfolio Services